Registry for patients undergoing advanced endoscopy procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Calgary Registry for Advanced and Therapeutic Endoscopy (CReATE) is a prospective multi-centre registry that collects data from adult patients undergoing endoscopic retrograde pancreatography (ERCP) for various biliary and pancreatic diseases. The study captures comprehensive pre-procedural, procedural, peri-procedural, and post-procedural data in real-time through a dedicated research assistant. Patient outcomes are evaluated through medical record reviews and follow-up phone interviews 30 days post-procedure. This registry also supports ongoing prospective studies and randomized trials in the field.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* any standard indication for ERCP, in the absence of standard contraindications;
* age 18 years or over;
* ability and willingness to give informed consent to be included in the registry and/or to involvement in one (or more) prospective sub-studies, or accompaniment by a surrogate who is willing and able to provide consent.

Exclusion Criteria:

-none other than inverses of above.

Where it's running

• University of Calgary
  Calgary, Alberta, Canada Recruiting

Study contacts

• Study coordinator: Nauzer Forbes, MD, MSc
• Email: nauzer.forbes@ucalgary.ca
• Phone: 403-592-5089

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Intensive 4-week postoperative multimodal rehab after proximal pancreatic surgery

  This study tests whether a 4-week multimodal rehabilitation program can help adults who have severe complications after proximal pancreatic surgery recover better.

  Recruiting IRCCS San Raffaele · Milan · NCT07768384

• New lipase NHS7108 safety and potential efficacy in adults with exocrine pancreatic insufficiency

  A 2-period study tests whether the new lipase NHS7108 works safely for adults with EPI by comparing it to the standard pancrelipase (Zenpep) at several doses over 14 days each.

  Recruiting at 7 sites Phase 2 Société des Produits Nestlé (SPN) · Scottsdale, Arizona and 38 other locations · NCT07559175

• Dabrafenib and trametinib for rare cancers with BRAF V600 mutations

  This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.

  Recruiting at 15 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT07440290

• Early diagnosis of pancreatic cancer using duodenal fluid biomarkers

  This project will see if pancreatic fluid collected during routine endoscopy can help detect early pancreatic cancer in adults.

  Recruiting at 3 sites Asan Medical Center · Aurora, Colorado and 2 other locations · NCT07030348

• Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis

  We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.

  Recruiting Phase 4 Medical University of Warsaw · Warsaw · NCT07024199

• Using Ondansetron to Prevent Pancreatitis After ERCP

  This study is testing if the medication ondansetron can help prevent pancreatitis in adults who are having an ERCP procedure.

  Recruiting Phase 3 Tanta University · Tanta · NCT06861010

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.